Analysis reveals factors underlying COVID-19 spread in Brazil

6 May 2021
Diane Li
Assistant Editor

Industry news

An overall failure in Brazil to implement prompt, coordinated, and equitable responses fueled COVID-19’s spread in a context of stark local socioeconomic and health care inequalities, according to an analysis from researchers at Harvard T.H. Chan School of Public Health.

Researchers analyzed the fast spread of COVID-19 cases and deaths across Brazilian states over a nine-month period in 2020. Factors at play in the swift and uneven spread of disease included disparities in health resources and income, lack of containment measures, politicization of the pandemic, and varied responses across states and cities. Based on their findings, the researchers warned that the P.1 variant, first documented in Brazil and already fueling a record number of cases and deaths and the near collapse of the hospital system, is likely to spur the emergence of new variants, isolate Brazil as a threat to global health security, and lead to an avoidable humanitarian crisis.

The analysis was published online on April 14, 2021, in Science.

“Our research is the most detailed subnational analysis of COVID-19 in Brazil—both over time and geography,” said co-author Marcia de Castro, Andelot Professor of Demography at Harvard Chan School. “It highlights that inequalities alone cannot explain the patterns and speed of movement of COVID to the interior of the country. Our results gave a preview of what we are seeing in Brazil now with P.1.”

Brazil has a universal, comprehensive, and free-of-charge health care system, but the country is also large and unequal, with disparities in income and quantity and quality of health resources. Politicization of the pandemic affected the creation of and compliance with public health measures, such as physical distancing. The result was concurrent and varied COVID-19 epidemics across the country.

To understand, measure, and compare the spread of COVID-19 in various parts of the country, the researchers used daily data, from February 23 to October 10, 2020, from Brazil’s State Health Offices. Their analysis indicated that some states with effective local responses, such as Ceará, were resilient and limited fatalities despite experiencing a near-collapse of the hospital system. Meanwhile, other states with comparatively more resources, such as Rio de Janeiro, failed to contain the spread of COVID-19.

The researchers’ work indicates that without immediate containment, coordinated epidemiological and genomic surveillance measures, and an effort to vaccinate the largest number of people in the shortest possible time, the continued propagation of the P.1 variant will likely resemble the spread of cases and deaths during 2020, leading to significant additional loss of lives.

“Therefore, the recommendation as Brazil confronts the P.1 variant remains the same as it was for the virus’s initial spread: prompt and equitable responses, coordinated at the federal level, to mitigate fast virus propagation and disparities in outcomes,” said Castro.

Other Harvard Chan School researchers who contributed to the study include Sun Kim and Susie Gurzenda.

For more of the latest science news, straight to your inbox, become a member of SelectScience for free today>>

Links

Tags

ImmunologyImmunological techniques measure and characterize immune responses. Immunology kits and analysis systems often use techniques such as ELISA, radioimmunoassay (RIA) and immunodiffusion assays, Immunohistochemistry, and flow cytometry. Immunologists use equipment such as flow Cytometers, plate readers, plate washers and fluorescent microscopes.Clinical ChemistryBiochemistry (or clinical chemistry) involves the analysis of bodily fluids using chemical tests. Techniques used include HPLC, chromatography, spectroscopy, mass spectrometry, immunochemical, electrophoresis, turbidometric / spectrophotometric assay, MRI and ISE analysis. Tests are often carried out on plasma or serum but urine (urinalysis) and fecal specimens are also processed.Clinical GeneticsMolecular Genetics covers the analysis of hereditary genetic disease and chromosomal abnormalities. Genetics can be analysed using DNA, RNA, and protein microarrays, PCR, RT PCR and DNA sequencing. Genetic equipment includes genetic workstations, thermal cyclers, cooling blocks and electrophoresis products. Diagnostic kits are used for DNA / RNA extraction and purification.Clinical MicrobiologyMicrobiology is the study of microorganisms including protists, prokaryotes, fungi, and, often, viruses. Microorganisms are a useful research tool as genetic vectors and, in immunology, for antibiotic susceptibility testing, cellular biology and genetics. Microorganisms commonly grow readily in incubators with microbial culture media; this can contain chromogenic supplements to differentiate between cell lines. Estimate your culture’s density of microorganisms with colony counters, or screen and select colonies for desirable clones with automated colony pickers. Additionally, equipment is available to monitor environments for the presence of microbes and identify with microbial identification instruments. Find the best microbiology products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Clinical TrialsClinical Trials, an essential part of drug discovery process, assess the safety and effectiveness of a new medication or device in the pharmaceutical industry. Clinical Trials are a phased process (Phase 0, Phase I, Phase II, Phase III and Phase IV) which begins after initial preclinical testing.Respiratory InfectionsRespiratory infections are caused by pathogens such as bacteria, viruses, and fungi, leading to diseases like pneumonia, tuberculosis, and COVID-19. It is important to identify respiratory infections quickly in patients to ensure appropriate treatment and care, and to prevent sepsis. Browse our peer-reviewed product directory to find the best tools for respiratory infection detection, compare products, check reviews, and get pricing directly from manufacturers.Vaccine DevelopmentVaccine development focuses on creating immunizations to protect against infectious diseases. The process involves identifying antigens, developing and testing vaccine efficacy, and ensuring safety through preclinical testing and multiple clinical trial phases. Scientists use various approaches, including weakened or inactivated viruses, protein subunits, or mRNA. Advanced platforms and rapid diagnostic tools aid in vaccine research and testing. Explore vaccine development solutions in our peer-reviewed product directory; compare products, read reviews, and get pricing directly from manufacturers. CoronavirusCoronaviruses are a large family of viruses that can cause illnesses ranging from the common cold to more severe diseases like COVID-19. Research into the biology, transmission, and treatment of coronaviruses has become a global priority, particularly since the emergence of SARS-CoV-2. Understanding the virus�s structure and behavior is essential for developing vaccines, diagnostics, and antiviral treatments. Explore our peer-reviewed product directory to discover the latest research tools, diagnostic tests, vaccines, and treatments for coronavirus, compare products, read reviews, and receive pricing directly from manufacturers.Covid-19COVID-19, caused by the SARS-CoV-2 virus, has led to a global health crisis with profound impacts on societies and economies. Research into diagnostics, vaccines, treatments, and understanding viral mechanisms continues to evolve. The pandemic has accelerated innovations in healthcare and biopharmaceuticals, including novel vaccine platforms and rapid testing technologies. Browse our peer-reviewed product directory to find top COVID-19 testing kits, research tools, vaccines, and treatments, compare products, read reviews, and receive direct pricing from manufacturers.Infectious DiseasesInfectious diseases are caused by pathogens such as bacteria, viruses, and fungi. Effective detection, prevention, and treatment are crucial to control outbreaks and improve public health. Diagnostic tools, vaccines, and antimicrobial treatments are essential components of managing these diseases. Research into emerging pathogens and resistance patterns continues to evolve. Browse our peer-reviewed product directory to find the best diagnostic tools, prevention solutions, and treatment options; compare products, read customer reviews, and get pricing directly from manufacturers.